Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Protective Effect of DWP-04 Against Hepatotoxicity Induced by D-galactosamine

흰쥐에서 DWP-04가 D-galactosamine에 의해 유도된 간독성의 보호효과

  • Published : 2005.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was conducted to investigate the biological activity and hepatoprotective effect of DWP-04 [DDB : selenium yeast: glutathione (31.1 : 6.8 : 62.1(w/w/w)] in D-galactosamine (GaIN) intoxicated rats. The DWP-04 (50, 100 or 200 mg/kg) or its vehicle was orally administered everyday before the start of GaIN injection (400 mg/kg, ip) for two weeks and animal decapitated for 24 hrs after GaIN­injected. The activities of serum enzymes, markers of liver function, were increased in the GaIN group compared to normal group and significantly lowered in the DWP-04 pretreated group than in the GaIN group. Hepatic lipid peroxide level and activities of phase 1 enzymes were significantly higher than those of GaIN group compared to normal group and lower in the DWP-04 pretreated group than in the GaIN group, and phase II enzyme activities in liver were lower in the GaIN group than in the normal group and were increased in the DWP-04 pretreated group than in the GaIN group. Total hepatic glutathione content and glutathione biosynthesis enzymes were lower in the GaIN group than in the normal group and were increased in the DWP-04 pretreated group than in the GaIN group. Therefore, the current results indicated that DWP-04 administration alleviated the GaIN-induced adverse effect through enhancing the antioxidant enzyme activities.

간기능 보호 작용이 있는 것으로 알려진 DDB, selenium과 glutathione의 혼합제제인 DWP-04의 간보호 작용을 검토할 목적으로 DWP-04를 실험동물에 경구로 투여하고서 D-galactosamine으로 간독성을 유발하여 혈액의 변동 및 간 조직에서의 활성산소 생성계 및 해독계의 활성에 미치는 영향을 관찰한 결과 GaIN의 단독투여는 대조군에 비하여 혈중 간 기능 지표효소 및 간 조직에서의 지질과산화의 함량이 현저히 증가하였으나, DWP-04의 전처리로 현저히 감소되었다. CaIN의 단독 투여로 활성산소의 생성계인 phase 1계의 효소가 현저히 증가하던 것이 DWP-04의 처리로 억제되었으며 해독계인 phase II계의 효소는 GaIN의 투여로 대조군에 비하여 억제되던 것이 DWP-04의 전처리로 정상군에는 미치지 않으나 유의성 있게 증가되었다. 간 조직중 glutathine의 함량은 CaIN의 투여로 현저히 억제되었으며 DWP-04의 투여로 증가하였는데 이러한 결과는 DWP-04의 투여로 glutathione peroxidase의 활성보다는 $\gamma-glutamylcysteine$ synthetase의 활성을 조절한 결과로 생각된다. 이상의 결과를 종합하여 볼 때 DWP-04의 투여는 활성산소의 생성 및 해독계를 조절하므로서 GaIN으로 인한 간손상을 보호하는 효과가 있는 것으로 사료된다.

Keywords

References

  1. Decker, K. and D. Keppler, 1974. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71, 77-106 https://doi.org/10.1007/BFb0027661
  2. Wang, J. and A. Wendel. 1990. Studies on the hepatotoxicity of galactosamine endotoxin or galactosamine/TNF in the perfused mouse liver. Biochem. Pharmacol. 39, 267-270 https://doi.org/10.1016/0006-2952(90)90025-G
  3. EI-Mofty, S. K., M. C. Scrutton, A. Serroni, C. Nicolini and J. L. Farber. 1975. Early, reversible plasma membrane injury in galctosamine-induced liver cell death. Am. J. Pathol. 79, 579-595
  4. Keppler, D., R. Lesch, W. Reutter and K. Decker. 1968. Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol. 9, 279-290 https://doi.org/10.1016/0014-4800(68)90042-7
  5. Farber, J. L., G. Gill and Y. Konishi. 1973. Prevention of galactoxamine-induced liver cell necrosis by uridine. Am. J. Pathol. 72, 53-62
  6. Lesch, R., W. Reutter, D. Kippler and K. Decker. 1969. Liver restitution after acute galactosamine hepatitis: Autoradiographic and biochemical studies in rats. Exp. Mol. Pathol. 12, 58-69 https://doi.org/10.1016/0014-4800(70)90075-4
  7. Perira, B., L. F. Rosa, D. A. Sato, E. J. Bechara and R. Curl. 1995. Hormonal regulation of superoxide dismutase, catalase and glutathione peroxidase activities in rat macrophages. Bio. Chem. Pharmacol. 50, 2093-2098 https://doi.org/10.1016/0006-2952(95)02116-7
  8. Imura, T., S. Ameshima and S. Miyabo. 1995. Glutathione peroxidase. Nippon Rinshoy., 53, 428-431
  9. Sakurai, H. and K. Tsuchya. 1975. A tentative recommendation for the maximum daily intake of selenium. Environm. Phys. Biochem. 5, 107-118
  10. Harrison, I., D. L. John and G. S. Fell. 1996. DisAribution of selenium in human blood plasma and serum. Amalyct. 121, 189-194
  11. Wang, X. L. 1894. Clinical effect of DDB pilules on 56 cases of chronic viral hepatitis B. New Drugs Clinic. 3, 13-15
  12. Liu, Z., G. Liu and S. Zhang. 1996. Reversing effect of DDB on the phenotypes of human nepatocarcinoma cell fine. Chung Hua I Hsucb Tsa Chih 75, 696-678
  13. Buege, J. A. and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymology Vol. 52, 302-310 https://doi.org/10.1016/S0076-6879(78)52032-6
  14. Griffith, O. W. 1980. Determination of glutathione and glutathione disulfide using glutathione reducetase and 2-vinylpyridine. Anal. Biochem. 106, 207-212 https://doi.org/10.1016/0003-2697(80)90139-6
  15. Stirpe, F. and C. E. Della. 1969. The regulation of rat liver xanthine oxidase: Conversion in vitro of the enzyme activity from dehydrogenase (Type D) to oxidase (Type O). J. Biol. Chem. 244, 3855-3863
  16. Rajagopalan, K. V., J. Fridobich and P. Handler. 1962. Hepatic aldegyde oxidase. In Purification and properties. J. BioI. Chem. 237, 922-928
  17. Nash, T. 1953. The colorimetric estimation of formaldehyde by means of the hentisch reaction. J. Biol. Chem. 55, 416-423
  18. Bidlack, W. R. and G. L. Lowry. 1982. Multiple drug metabolism: p-Nitroanisole reversal off acetone enhanced aniline hydroxylation. Biochem. Pharmacol. 31, 311-317 https://doi.org/10.1016/0006-2952(82)90176-9
  19. Habig, W. H., M. J. Pabist and W. B. Jakoby. 1974. Glutathion S-trasferase: Thefirst enrymatic step in mercapturic acid formation. J. BioI. Chem. 249, 7130-7139
  20. Marklund, S. and G. Marklund. 1974. Involvement of the superoxide anion fadical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-473 https://doi.org/10.1111/j.1432-1033.1974.tb03714.x
  21. Aebi, H. 1973. Catalase. Method of Enzymatic Analysis. pp. 673-698, Vol. 2, Vergmeyer MU, ed, Academic Press, New York
  22. Pagila, E. D. and W. N. Valentine. 1967. Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J. Lab. Clin. Med. 70, 158-169
  23. Meister, A. and P. G. Richman. 1975. Regulation of $\gamma$-glutamyl -cysteine synthesis by nonallosteric feedback inhibition by glutathione. J. BioI. Chem. 250, 1422-1429
  24. Mize, C. E. and R. G. Langdon. 1962. Hepatic glutathione reductase: I. Purification and general kinetic properties. J. Biol. Chem. 237, 1589-1595
  25. Lowry, O. H., N. J. Rodebrough, A. L. Farr and R. J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275
  26. Yi, KN. and J. Q. Kim. 1988. Clinical Olemistry. pp. 301-309, Euigakmunawhasa, Seoul
  27. Gary, P. C. 2002. Effect of the inhibition of the metabolism of 4-vinylphenol on its hepatotoxicity and pneumotoxicity in rats and mice. Toxicology 179, 129-136 https://doi.org/10.1016/S0300-483X(02)00340-2
  28. Szasa, F. 1969. Kinetic photometric method for serum glutamytrans-ferase. Clin. Chem. 15, 124-136
  29. Zieve, L., W. R. Anderson, and R. Dozeman. 1988. Haptic regenerative enzyme activity after diffuse injury with galactosamine, relationship to histologic alterations. J. Lab. Clin. Med. 115, 575-582
  30. Hong, S. S., G. T. Gibney, M. Esquilin, J. Yu and Y. Xia. 2004. Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia. Brain Research. 1009, 195-202 https://doi.org/10.1016/j.brainres.2004.03.004
  31. Um, H. K., H. S. Kim and J. W. Choi. 2000. Therapeutic effects of bergenin and actylbergenin on galactosamineinduced hepatotoxicity in rats. Kor. J. Pharmacol. 31, 351-356
  32. Halliwell, B. 1978. Biochemical mechanism accounting for ghe toxic action of oxygen on living organisms: The key role of superoxide dismutase. Cell. Biol. Int. Rep. 2, 113-128 https://doi.org/10.1016/0309-1651(78)90032-2
  33. Awasthi, Y. C., E. Beutler and S. K. Srivastava. 1975. Purification and properties of human erythrocyte glutathione peroxidase. J. Biol. Chem. 250, 5144-5149
  34. Ahokas, J. T., C. Davies, P. J. Ravenscroft and B. T. Emmerxon. 1984. Inhibition of souble glutathione S-transferase by diuretic drugs. Biochem. Pharmacol. 33, 1929-1932 https://doi.org/10.1016/0006-2952(84)90549-5
  35. Battelli, M. G., Corte E. Della and F. Stirpe. 1972. Xanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat. Biochem. J. 126, 747-749
  36. Mccord, J. M. and I. Fridovich. 1968. The reduction of cytochrome C by milk xanthine oxidase. J. Biol. Chem. 243, 5753-5760
  37. Wolpert, M. K., J. R. Althaus and D. G. Johns. 1973. Nitroreductase activity of mammalian liver aldehyde oxidase. J. Pharmacol. Exp. Ther. 185, 202-213
  38. Sato, I. Y. 1966. Activation and inhibition of microsomal hydroxylation by ethyl isocyanide Biochem. Biophys. Res. Comm. 25, 80-86 https://doi.org/10.1016/0006-291X(66)90643-7
  39. Halliwell, B. 1978. Biochemical mechanism accounting for the toxic action of oxygen on living organisms: The key role of superoxide dismutase. Cell. BioI. Int. Rep. 2, 113-128 https://doi.org/10.1016/0309-1651(78)90032-2
  40. Wendel, A. and S. Feuerstein. 1981. Drug-induced lipid peroxidation in mice-I. Modulation by monooxygenase activity, glutathione and selenium status. Biochem. Pharmacol. 3D, 2513-2520
  41. Meister, A. and M. E. Anderson. 1983. Glutathione. Annu. Rev. Biochem. 52, 711-760 https://doi.org/10.1146/annurev.bi.52.070183.003431
  42. Rikans, J. E. and S. D. Kosanke. 1981. Errect of aging on liver glutathione levels and hepatocellular injury from carbon tetrachloride, allyl alcohol or galactosamine. Drug. Chem. Toxicol. 7, 595-604 https://doi.org/10.3109/01480548409042822
  43. William, R. M. and A. Meister. 1987. Enzymatic synthesis of novel glutathione analogs. Analytical Biochemistry 2, 487-493
  44. Susana M. H., M. Baptista and E. P. Ruy. 1997. Glutathione metabolism in hepatomous liver of rats treated with diethylnitrosamine. Biochim. Biophy. Acta. 12, 157-168
  45. Dodds, M. G. and R. D. Foord. 1970. Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. Br. J. Pharmacol. 40, 227-236 https://doi.org/10.1111/j.1476-5381.1970.tb09916.x

Cited by

  1. Hepatoprotective Activity of Dandelion (Taraxacum officinale) Water Extract against D-Galactosamine-Induced Hepatitis in Rats vol.37, pp.2, 2008, https://doi.org/10.3746/jkfn.2008.37.2.177
  2. Protective Effect of Semisulcospira libertina Extract on Induced Hepatitis in Rats vol.25, pp.5, 2015, https://doi.org/10.5352/JLS.2015.25.5.539
  3. Effect of Fermented Water Extracts from Ligularia fischeri on Hepatotoxicity Induced by D-Galactosamine in Rats vol.44, pp.10, 2015, https://doi.org/10.3746/jkfn.2015.44.10.1422
  4. Effect of Semisulcospira libertina Extract on Hepatic Injury Induced by D-galactosamine vol.36, pp.4, 2018, https://doi.org/10.11626/KJEB.2018.36.4.498